Also, considering ZFP14's role as a downstream target of TP53,14 it is plausible that multiple factors contribute to ZFP14's aberrant expression in ccRCC, not just m6A dysregulation. This evidence concerns the gene ZFP14 and nonpapillary renal cell carcinoma.